Differential regulation of hepatic cytochrome P450 monooxygenases in streptozotocin-induced diabetic rats

References

• Gonzalez FJ. The molecular biology of cytochrome P450s. Pharmacol Rev 1989; 40: 243–288
   Web of Science ®Google Scholar
• Nordblom GD, Coon MJ. Hydrogen peroxide formation and stoichiometry of hydroxylation reactions catalyzed by highly purified liver microsomal cytochrome P-450. Arch Biochem Biophys 1977; 180: 343–347
   PubMed Web of Science ®Google Scholar
• Kuthan H, Tsuji H, Graf H, Ullrich V. Generation of superoxide anion as a source of hydrogen peroxide in a reconstituted monooxygenase system. FEBS Lett 1978; 91: 343–345
   PubMed Web of Science ®Google Scholar
• White RE. The involvement of free radicals in the mechanisms of monooxygenases. Pharmacol Ther 1991; 49: 21–42
   PubMed Web of Science ®Google Scholar
• Gutteriidge JM. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett 1986; 201: 291–295
   PubMedGoogle Scholar
• Liu H, Bigler SA, Henegar JR, Baliga R. Cytochrome P450 2B1 mediates oxidant injury in puromycin-induced nephrotic syndrome. Kidney Int 2002; 62: 868–876
   PubMedGoogle Scholar
• Baliga R, Zhang Z, Baliga M, Shah SV. Evidence for cytochrome P-450 as a source of catalytic iron in myoglobinuric acute renal failure. Kidney Int 1996; 49: 362–369
   PubMed Web of Science ®Google Scholar
• Bysani GK, Kennedy TP, Ky N, Rao NV, Blaze CA, Hoidal JR. Role of cytochrome P-450 in reperfusion injury of the rabbit lung. J Clin Invest 1990; 86: 1434–1441
   PubMed Web of Science ®Google Scholar
• Paller MS, Jacob HS. Cytochrome P-450 mediates tissue-damaging hydroxyl radical formation during reoxygenation of the kidney. Proc Natl Acad Sci USA 1994; 91: 7002–7006
   PubMed Web of Science ®Google Scholar
• Liu H, Shah SV, Baliga R. Cytochrome P-450 as a source of catalytic iron in minimal change nephrotic syndrome in rats. Am J Physiol Renal Physiol 2001; 280: F88–F94
   Web of Science ®Google Scholar
• Koo JR, Ni Z, Oviesi F, Vaziri ND. Antioxidant therapy potentiates antihypertensive action of insulin in diabetic rats. Clin Exp Hypertens 2002; 24: 333–344
   PubMed Web of Science ®Google Scholar
• Koo JR, Vaziri ND. Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species. Kidney Int 2003; 63: 195–201
   PubMed Web of Science ®Google Scholar
• Sindhu RK, Koo J-R, Roberts CK, Vaziri ND. Dysregulation of hepatic superoxide dismutase, catalase and glutathione peroxidase in diabetes: Response to insulin and antioxidant therapies. Clin Exptl Hypertens 2004; 26: 43–53
   PubMed Web of Science ®Google Scholar
• Prough RA, Burke MD, Mayer RT. Direct fluorometric methods for measuring mixed-function oxidase activity. Methods Enzymol 1978; 52: 372–377
   PubMedGoogle Scholar
• Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyerelsen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC, Nebert DW. The P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996; 6: 1–42
   PubMedGoogle Scholar
• Sindhu RK, Reisz-Porszasz S, Hankinson O, Kikkawa Y. Induction of cytochrome P4501A1 by photooxidized tryptophan in Hepa lclc7 cells. Biochem Pharmacol 1996; 52: 1883–1893
   PubMedGoogle Scholar
• Sindhu RK, Rasmussen RE, Kikkawa Y. Induction of cytochrome P450 1A1 by ozone-oxidized tryptophan. Adv Exptl Med Biol 1999; 467: 409–418
   PubMedGoogle Scholar
• Sindhu RK, Wagner FE, Kikkawa Y. Induction of cytochrome P450 1A1 and 1B1 by photooxidized tryptophan in transformed human keratinocytes. Adv Exptl Med Biol 2003; 527: 297–306
   PubMed Web of Science ®Google Scholar
• Okamoto T, Mitsuhashi M, Fujita I, Sindhu RK, Kikkawa Y. Induction of cytochrome P450 1A1 and 1A2 by hyperoxia. Biochem Biophys Res Commun 1993; 197: 878–885
   PubMed Web of Science ®Google Scholar
• Khatsenko OG, Sindhu RK, Kikkawa Y. Undernutrition during hyperoxic exposure induces CYP2E1 in rat liver. Arch Toxicol 1997; 71: 684–689
   PubMed Web of Science ®Google Scholar
• Sindhu RK, Sakai H, Kikkawa Y. Effect of hyperoxia on rat pulmonary and hepatic cytochrome P450 monooxygenases. Arch Toxicol 2000; 73: 540–546
   PubMedGoogle Scholar
• Shimada T, Fujii-Kuriyana Y. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci 2004; 95: 1–6
   PubMed Web of Science ®Google Scholar
• Penn A, Snyder C. Arteriosclerotic plaque development is promoted by polynuclear aromatic hydrocarbons. Carcinogenesis 1988; 9: 2185–2189
   PubMed Web of Science ®Google Scholar
• Ball P, Knuppen R. Catecol oestrogen (2-and 4-hydroxyestrogens): Chemistry, biogenesis, metabolism, occurance and physiological significance. Acta Endocrinol 1980; 232(93 (suppl.))1–127
   Google Scholar
• Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbotham S, Johansson SL, Patil KD, Gross ML, Gooden JK, Ramanathan R, Cerny RL, Rogan EG. Molecular origin of cancer: Catecol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA 1997; 94: 10937–10942
   PubMed Web of Science ®Google Scholar
• Pineau T, Fernandez-Salguero P, Lee SST, McPhail T, Ward JM, Gonzalez F. Neonatal lethality associated with respiratory distress in mice lacking cytochrome P450 1A2. Proc Natl Acad Sci USA 1995; 92: 5134–5138
   PubMed Web of Science ®Google Scholar
• Cornelis MC, El-Sohemy A, Campos H. Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction. J Medical Genetics 2004; 41: 758–762
   PubMed Web of Science ®Google Scholar
• Hankinson O. The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 1995; 35: 307–340
   PubMed Web of Science ®Google Scholar
• Tang YM, Wo YY, Stewart J, Hawkins AL, Griffin CA, Sutter TR, Greenlee WF. Isolation and characterization of the human cytochrome P450 CYP1B1 gene. J Biol Chem 1996; 271: 28324–28330
   PubMed Web of Science ®Google Scholar
• Quattrochi LC, Vu TV, Tukey RH. The human CYP1A2 gene and induction by 3-methylcholanthrene. J Biol Chem 1994; 269: 6949–6954
   PubMed Web of Science ®Google Scholar
• Chowdhury RC, Chowdhury NR, Wolkoff AW, Arias IM. Heme and bile pigment metabolism. The liver: Biology and pathology, IM Arias, JL Boyer, N Fausto, WB Jakoby, DA Schachter, DA Schafritz. Raven Press, New York 1994; 471–504
   Google Scholar
• Abraham NG, Kappas A. Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med 2005; 39: 1–25
   PubMed Web of Science ®Google Scholar
• Morita T. Heme oxygenase and atherosclerosis. Arterioscler Thromb Vasc Biol 2005; 25: 1786–1795
   PubMed Web of Science ®Google Scholar
• Iyanagi T, Watanabe T, Uchiyama Y. The 3-methylcholanthrene-inducible UDP-glucuronosyltranferase defficiency in the hyperbilirubinemic rat (Gunn rat) is caused by a-1 frameshift mutation. J Biol Chem 1989; 264: 21302–21307
   PubMed Web of Science ®Google Scholar
• Kapitulnik J, Ostrow JD. Stimulation of bilirubin catabolism in jaundiced Gunn rats by an inducer of microsomal mixed-function monooxygenases. Proc Natl Acad Sci USA 1978; 75: 682–685
   PubMed Web of Science ®Google Scholar
• De Matteis F, Trenti T, Gibbs AH, Greig JB. Inducible bilirubin-degrading system in the microsomal fraction of rat liver. Mol Pharmacol 1989; 35: 831–838
   PubMed Web of Science ®Google Scholar
• Kapitulnik J, Gonzalez F. Marked endogenous activation of the CYP1A1 and CYP1A2 genes in the congenitally jaundiced Gunn rat. Mol Pharmacol 1993; 43: 722–725
   PubMed Web of Science ®Google Scholar
• Sinal CJ, Bend JR. Aryl hydrocarbon receptor-dependent induction of Cyp1a1 by bilirubin in mouse hepatoma lclc7 cells. Mol Pharmacol 1997; 52: 590–599
   PubMed Web of Science ®Google Scholar
• Phelan D, Winter GM, Rogers WJ, Lam JC, Denison MS. Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin. Arch Biochem Biophys 1998; 357: 155–163
   PubMed Web of Science ®Google Scholar
• Tunon MJ, Gonzalez P, Garcia-Pardo LA, Gonzalez J. Hepatic transport of bilirubin in rats with streptozotocin-induced diabetes. J Hepatol 1991; 13: 71–77
   PubMedGoogle Scholar
• Knoop DR. Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J 1992; 6: 724–730
   PubMedGoogle Scholar
• Knoop DR, Tierney DJ. Multiple mechanisms in the regulation of ethanol-inducible cytochrome P450IIEI. Bioessays 1990; 12: 429–435
   PubMedGoogle Scholar
• Song B-J, Matsunaga T, Hardwick JP, Park SS, Veech RL, Yang CS, Gelboin HV, Gonzalez FJ. Stabilization of cytochrome P450j messenger ribonucleic acid in the diabetic rat. Mol Endocrinol 1987; 8: 542–547.
   Google Scholar
• Knoop DR, Crump BL, Nordbloom GO, Coon MJ. Immunochemical evidence for induction of the alcohol oxidising cytochrome—P450 of rat liver microsomes by diverse agents: Ethanol, imidazole, trichloroethylene, acetone, pyrazole and isoniazid. Proc Natl Acad Sci USA 1985; 82: 4065–4069
   PubMedGoogle Scholar
• Ma Q, Dannan GA, Guengerich FP, Yang CS. Similarities and differences in the regulation of hepatic cytochrome P450 enzymes by diabetes and fasting in male rats. Biochem Pharmacol 1989; 38: 3179–3184
   PubMed Web of Science ®Google Scholar
• Carriere V, Berthou F, Baird S, Belloc C, Beaune P, de Waziers I. Human cytochrome P450 2E1 (CYP 2E1): From genotype to phenotype. Pharmacogenetics 1996; 6: 203–211
   PubMedGoogle Scholar
• Chen TL, Chen SH, Tai TY, Chao CC, Park SS, Guengerich FP, Ueng TH. Induction and suppression of renal and hepatic cytochrome P450-dependent monooxygenases by acute and chronic streptozotocin diabetes in hamsters. Arch Toxicol 1996; 70: 202–208
   PubMedGoogle Scholar
• Gupta RR, Agarwal CG, Shukla GS, Ali B. Cytochrome P450-dependent oxidation and glutathione conjugation of xenobiotics in alloxan-induced diabetic rats. Res Commun Mol Pathol Pharmacol 1997; 98: 231–236
   PubMedGoogle Scholar
• Raza H, Ahmed I, John A, Sharma AK. Modulation of xenobiotic metabolism and oxidative stress in chronic streptozotocin-induced diabetic rats fed with Momordica charantia fruit extract. J Biochem Mol Toxicol 2000; 14: 131–139
   PubMed Web of Science ®Google Scholar
• Schoedel KA, Sellers EM, Tyndale RF. Induction of CYP2B1/2 and nicotine metabolism by ethanol in rat liver but not rat brain. Biochemical Pharmacol 2001; 62: 1025–1036
   PubMed Web of Science ®Google Scholar
• Chang THK, Weber GF, Crespi CL, Waxman DJ. Differential activation of cyclophosphamide and ifosphamide by cytochromes P450 aB and 3A in human liver microsomes. Cancer Res 1993; 3: 5629–5637
   Google Scholar
• Lewis DFV, Lake BG, Dickins M, Eddershaw PJ, Tarbit MH, Goldfarb PS. Molecular modeling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: Evaluation of CYP2B6 substrate characteristics, the cytochrome b5 binding site and comparisons with CYP2B1 and CYP2B4. Xenobiotica 1999; 29: 361–393
   PubMed Web of Science ®Google Scholar
• Poet TS, Brendel K, Halpert JR. Inactivation of cytochromes P450 2B protects against cocaine-mediated toxicity in rat liver slices. Toxicol Appl Pharmacol 1994; 126: 26–32
   PubMed Web of Science ®Google Scholar
• Liu H, Bigler SA, Henegar JR, Baliga R. Cytochrome P450 2B1 mediates oxidant injury in puromycin-induced nephrotic syndrome. Kidney Int 2002; 62: 868–876
   PubMedGoogle Scholar
• Morgan ET, MacGeoch C, Gustafsson J-A. Hormonal and developmental regulation of expression of the hepatic microsomal steroid 16α-hydroxylase cytochrome P450 apoprotein in the rat. J Biol Chem 1985; 260: 11895–11898
   PubMed Web of Science ®Google Scholar
• Warrington JS, Von Moltke LL, Shader RI, Greenblat DJ. In vitro biotransformation of sildenafil (viagra) in the male rat: The role of CYP2C11. Drug Metab Dispos 2002; 30: 655–657
   PubMed Web of Science ®Google Scholar
• Kobliakov V, Popova N, Rossi L. Regulation of the expression of the sex-specific isoforms of cytochrome P450 in rat liver. Eur J Biochem 1991; 195: 585–591
   PubMedGoogle Scholar
• Skett P. Biochemical basis of sex differences in drug metabolism. Pharmacol Ther 1988; 38: 269–304
   PubMed Web of Science ®Google Scholar